Current Signal Transduction Therapy
SJR0.149
AE
AEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.149 | Q4 | 16.3% | |
| 2024 | — | — | 0.150 | Q4 | 19.9% | |
| 2023 | — | — | 0.188 | Q3 | 32.9% | |
| 2022 | — | — | 0.176 | Q4 | 33.3% | |
| 2021 | — | — | 0.151 | Q4 | 30.7% | |
| 2020 | — | — | 0.128 | Q4 | 14.8% | |
| 2019 | — | — | 0.142 | Q4 | 26.0% | |
| 2018 | — | — | 0.138 | Q4 | 18.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1574-3624
ISSN
2212-389X
country
AEcoverage
2007-2025